Investor Consortium Acquires Majority Stake in HistoSonics at $2.25B Valuation

Hologic Acquires Gynesonics

January 6, 2025

Medical Devices

Hologic has completed the acquisition of Gynesonics for approximately $350 million. The purchase adds the Sonata System — a minimally invasive intrauterine ultrasound-guided radiofrequency ablation platform for treating uterine fibroids — to Hologic's portfolio, expanding its capabilities in women's health surgical solutions.

Johnson & Johnson Acquires Shockwave Medical

April 5, 2024

Medical Devices

Johnson & Johnson will acquire Shockwave Medical for $335.00 per share in an all-cash transaction valued at approximately $13.1 billion including cash acquired. The deal adds Shockwave’s intravascular lithotripsy (IVL) technology to Johnson & Johnson MedTech, expanding J&J’s cardiovascular intervention portfolio and accelerating growth in high‑growth CAD and PAD markets.

Bioventus Inc. Acquires Misonix, Inc.

July 29, 2021

Medical Devices

Bioventus Inc. entered into a definitive agreement to acquire Misonix, Inc. in a cash-and-stock transaction that values Misonix at approximately $518 million on a fully diluted basis. The deal expands Bioventus' regenerative medicine and surgical solutions portfolio by adding Misonix's minimally invasive ultrasonic technologies and regenerative wound products and is expected to close in the fourth quarter of 2021 subject to customary approvals.

Zydus Lifesciences Acquires 85.6% Stake in Amplitude Surgical

March 11, 2025

Medical Devices

Zydus Lifesciences agreed to acquire an 85.6% controlling stake in French medtech company Amplitude Surgical for €6.25 per share (total consideration €256.8 million) and has completed the block acquisition. Zydus will file a mandatory simplified cash tender offer for the remaining shares at the same price with the aim of securing >90% of capital and implementing a squeeze-out and delisting; Amplitude Surgical is a Valence-based leader in lower-limb orthopaedic implants with ~429 employees and ~€111m revenue (FY Jun 2025).

Inotiv Acquires HistoTox Labs

April 13, 2021

Healthcare Services

Inotiv, Inc. has entered into an agreement to purchase substantially all assets of HistoTox Labs, a histopathology contract research organization, for $22.0 million in cash. The acquisition (subject to financing and customary closing conditions) expands Inotiv's pathology and histology capabilities, adds a Boulder, Colorado facility with digital pathology and immunohistochemistry capabilities, and is expected to retain all HistoTox employees.

Carlyle Acquires Minority Stake in Resonetics

December 3, 2021

Medical Devices

Funds managed by Carlyle have acquired a significant minority equity stake in Resonetics, valuing the specialized medical device contract manufacturer at approximately $2.25 billion. Carlyle will join existing investor GTCR as a meaningful shareholder while Sverica retains a minority position; the investment will support Resonetics’ continued organic growth, international expansion and add-on acquisition strategy.